Cargando…

Male Breast Cancer: From Molecular Genetics to Clinical Management

SIMPLE SUMMARY: Male breast cancer (MBC) is a rare disease. Genetic factors predispose to male breast cancer. Germline and/or genetic and/or epigenetic alterations at the somatic level identify a subset of male breast cancer that could differ from female breast cancer (FBC). Cancer genetic counselin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pensabene, Matilde, Von Arx, Claudia, De Laurentiis, Michelino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030724/ https://www.ncbi.nlm.nih.gov/pubmed/35454911 http://dx.doi.org/10.3390/cancers14082006

Ejemplares similares

Long-term complete response with third-line PARP inhibitor after immunotherapy in a patient with triple-negative breast cancer: a case report
por: Caputo, Roberta, et al.
Publicado: (2023)

Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors
por: Piezzo, Michela, et al.
Publicado: (2020)

The role of taxanes in triple-negative breast cancer: literature review
por: Mustacchi, Giorgio, et al.
Publicado: (2015)

How to Optimise Extended Adjuvant Treatment with Neratinib for Patients with Early HER2+ Breast Cancer
por: Untch, Michael, et al.
Publicado: (2021)

Rare tumours of the breast
por: Esposito, Emanuela, et al.
Publicado: (2019)

Progression-Free Survival and Overall Survival of CDK 4/6 Inhibitors Plus Endocrine Therapy in Metastatic Breast Cancer: A Systematic Review and Meta-Analysis
por: Piezzo, Michela, et al.
Publicado: (2020)

Uptake of Trastuzumab Biosimilars for the Treatment of HER2-Positive Breast Cancer: A Real-World Experience from a Cancer Center
por: Piezzo, Michela, et al.
Publicado: (2021)

Long Non-Coding RNA HOTAIR in Breast Cancer Therapy
por: Cantile, Monica, et al.
Publicado: (2020)

Triple-Negative Breast Cancer Comparison With Canine Mammary Tumors From Light Microscopy to Molecular Pathology
por: Amirkhani Namagerdi, Asadoor, et al.
Publicado: (2020)

Targeting Autophagy in Breast Cancer
por: Cocco, Stefania, et al.
Publicado: (2020)

Combined effect of obesity and diabetes on early breast cancer outcome: a prospective observational study
por: Buono, Giuseppe, et al.
Publicado: (2017)

Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series
por: Crispo, Anna, et al.
Publicado: (2013)

Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives
por: Cocco, Stefania, et al.
Publicado: (2020)

Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis
por: Gargiulo, Piera, et al.
Publicado: (2016)

A meta-analytic review of the relationship of cancer coping self-efficacy with distress and quality of life
por: Chirico, Andrea, et al.
Publicado: (2017)

Genetic Landscape of Male Breast Cancer
por: Campos, Fernando Augusto Batista, et al.
Publicado: (2021)

Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations
por: D’Arienzo, Andrea, et al.
Publicado: (2023)

Virtual Reality Rehabilitation Systems for Cancer Survivors: A Narrative Review of the Literature
por: Melillo, Antonio, et al.
Publicado: (2022)

Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer
por: Collina, Francesca, et al.
Publicado: (2015)

Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype
por: Capasso, Immacolata, et al.
Publicado: (2014)

Genetic characterization of breast cancer and implications for clinical management
por: Geyer, Felipe C, et al.
Publicado: (2009)

LncRNA HOTAIR up-regulation is strongly related with lymph nodes metastasis and LAR subtype of Triple Negative Breast Cancer
por: Collina, Francesca, et al.
Publicado: (2019)

Two novel sequence variants in MSH2 gene in a patient who underwent cancer genetic counseling for a very early-onset epithelial ovarian cancer
por: Pensabene, Matilde, et al.
Publicado: (2016)

Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management
por: Venetis, Konstantinos, et al.
Publicado: (2021)

Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management
por: Ivanova, Mariia, et al.
Publicado: (2023)

Lenvatinib, a molecule with versatile application: from preclinical evidence to future development in anti-cancer treatment
por: Capozzi, Monica, et al.
Publicado: (2019)

Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study
por: Di Maio, Massimo, et al.
Publicado: (2023)

Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis
por: Isgrò, Maria Antonietta, et al.
Publicado: (2021)

Ichthyosis with confetti: clinics, molecular genetics and management
por: Guerra, Liliana, et al.
Publicado: (2015)

Role of molecular genetics in the clinical management of cholangiocarcinoma
por: Normanno, N., et al.
Publicado: (2022)

Ribociclib plus letrozole in subgroups of special clinical interest with hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer: Subgroup analysis of the phase IIIb CompLEEment-1 trial
por: Cottu, Paul, et al.
Publicado: (2022)

An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project
por: Pelizzari, Giacomo, et al.
Publicado: (2018)

NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells
por: Quagliariello, Vincenzo, et al.
Publicado: (2020)

Floral humidity and other indicators of energy rewards in pollination biology
por: von Arx, Martin
Publicado: (2013)

The molecular genetics of breast cancer and targeted therapy
por: Suter, Rachel, et al.
Publicado: (2007)

Current state of surgical management for male breast cancer
por: Popa-Nimigean, Vladimir, et al.
Publicado: (2019)

Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis
por: Schettini, Francesco, et al.
Publicado: (2021)

Updates on the Role of Molecular Alterations and NOTCH Signalling in the Development of Neuroendocrine Neoplasms
por: von Arx, Claudia, et al.
Publicado: (2019)

ER+, HER2− advanced breast cancer treated with taselisib and fulvestrant: genomic landscape and associated clinical outcomes
por: Chen, Jessica W., et al.
Publicado: (2023)

A Psychosocial Genomics Pilot Study in Oncology for Verifying Clinical, Inflammatory and Psychological Effects of Mind-Body Transformations-Therapy (MBT-T) in Breast Cancer Patients: Preliminary Results
por: Cozzolino, Mauro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j44reg13vre0gillg49pfdfsud